COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,927 Articles (22,054 medRxiv, 7,873 bioRxiv)

Most recent first Previous |  Page 199: Articles 1981-1990  | Next

Neutralisation of SARS-CoV-2 Omicron subvariants BA.2.86 and EG.5.1 by antibodies induced by earlier infection or vaccination
Lassauniere, R., Polacek, C., Baig, S., Ellegaard, K., Escobar-Herrera, L. A., Fomsgaard, A., Spiess, K., Schwartz, O., Planas, D., Simon-Loriere, E., Schneider, U. V., Sieber, R. N., Stegger, M., Krause, T. G., Ullum, H., Jokelainen, P., Rasmussen, M.
10.1101/2023.10.01.560365 — Posted: 2023-10-02
The TMPRSS2 non-protease domains regulating SARS-CoV-2 Spike in mediated virus entry
Strobelt, R., Adler, J., Shaul, Y.
10.1101/2023.10.01.560357 — Posted: 2023-10-02
Protection of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort
Kirwan, P. D., Hall, V. J., Foulkes, S., Otter, A., Munro, K., Sparkes, D., Howells, A., Platt, N., Broad, J., Crossman, D., Norman, C., Corrigan, D., Jackson, C. H., Cole, M., Brown, C. S., Atti, A., Islam, J., SIREN Study Group, , Presanis, A., Charlett, A., De Angelis, D., Hopkins, S.
10.1101/2023.09.29.23296330 — Posted: 2023-10-02
Exploring the Correlation Between the COVID-19 Pandemic and Increased Daily Cigarette Consumption in Yogyakarta, Indonesia: A Machine Learning Approach
Nuryunarsih, D., Herawati, L., Ba'diah, A., Densu, J. D.
10.1101/2023.09.30.23296376 — Posted: 2023-10-02
The role of socio-economic disparities in the relative success of SARS-CoV-2 variants in New York City in early 2021
Vasylyeva, T. I., Havens, J. L., Wang, J. C., Luoma, E., Hassler, G. W., Amin, H., Di Lonardo, S., Taki, F., Omoregie, E., Hughes, S., Wertheim, J. O.
10.1101/2023.09.29.23296367 — Posted: 2023-10-02
Trends in Healthcare Service Disruptions and Associations with COVID-19 Outcomes among Patients with SMI vs. Non-SMI during COVID-19
Thiruvalluru, R. K., Sharma, M. m., Weissman, M. M., Olfson, M., keyes, K. M., Pathak, J., Xiao, Y.
10.1101/2023.09.29.23296176 — Posted: 2023-10-02
Dynamic Contact Networks of Residents of an Urban Jail in the Era of SARS-CoV-2
Jenness, S. M., Wallrafen-Sam, K., Schneider, I., Kennedy, S. M., Akiyama, M. J., Spaulding, A. C.
10.1101/2023.09.29.23296359 — Posted: 2023-10-02
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccination
Valk, A. M., Keijser, J. B. D., Dam, K. v., Stalman, E., Wieske, L., Steenhuis, M., Kummer, L. Y. L., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., Bosma, A. L., Horvath, B., Hijnen, D., Schreurs, C. R. G., van Kempen, Z., Killestein, J., Volkers, A. G., Tas, S., Boekel, L., Wolbink, G., Keijzer, S., Derksen, N., van Deelen, M., van Mierlo, G., Kuijpers, T. W., Eftimov, F., Ham, M. v., Brinke, A. t., Rispens, T.
10.1101/2023.09.29.23296354 — Posted: 2023-10-02
Simulation of COVID-19 Epidemic from Potential Viral Loads in Saudi Arabian Wastewater Treatment Plants
Meetei, M. Z., Msmali, A. H., Ahmadini, A. A. H., Alshqaq, S. S. A., Alnashiri, H. M.
10.1101/2023.09.30.23296175 — Posted: 2023-10-02
Synthesis, Insertion and Characterization of SARS-CoV-2 Membrane Protein Within Lipid Bilayers
Zhang, Y., Anbir, S., Mctiernan, J., Li, S., Worcester, M., Mishra, P., Colvin, M. E., Gopinathan, A., Mohideen, U., Zandi, R., Kuhlman, T. E.
10.1101/2023.09.30.560318 — Posted: 2023-10-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).